Cargando…
Epidermal growth factor receptor (EGFR): A rising star in the era of precision medicine of lung cancer
Lung cancer is a leading cause of cancer mortality worldwide. In tumors, the important role of noncoding RNA regulatory networks has been more and more reveal. EGFR has been identified as an oncogenic driver of NSCLC, especially activating mutations EGFR and its inhibition with specific TKIs can gen...
Autores principales: | Liu, Xiaomin, Wang, Ping, Zhang, Caiyan, Ma, Zhongliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564844/ https://www.ncbi.nlm.nih.gov/pubmed/28430586 http://dx.doi.org/10.18632/oncotarget.16854 |
Ejemplares similares
-
Editorial: Rising stars in precision medicine 2021: imprecise medicine is unethical in the big data era
por: Liebeskind, David S.
Publicado: (2023) -
Editorial: Rising stars in precise sustainable irrigation
por: Conesa, María R., et al.
Publicado: (2023) -
Rising Star
por: Wojtys, Edward M.
Publicado: (2012) -
MicroRNA-107-5p suppresses non-small cell lung cancer by directly targeting oncogene epidermal growth factor receptor
por: Wang, Ping, et al.
Publicado: (2017) -
Editorial: Frontiers in Cardiovascular Medicine: Rising Stars 2021
por: Wang, Lijun, et al.
Publicado: (2022)